sewage and wastewater treatment facilities
Scope
Date
~
-
Hydrogen economy
SK E&S, Plug Power agree to strengthen hydrogen partnership
SK E&S CEO Choo Hyung-wook met with Plug Power CEO Andy Marsh at CES 2023 in Las Vegas on Jan. 5 to discuss ways to strengthen cooperation in th...
Jan 11, 2023 (Gmt+09:00)
-
Energy
POSCO to enter palm oil refining market in Indonesia
POSCO International Co., a trading arm of South Korea’s steel giant POSCO Co., will build a palm oil refining plant in Indonesia to foray into...
Jan 10, 2023 (Gmt+09:00)
-
Construction & Planning
Samsung Engineering wins $1.3 bn order to build ethylene plant in Qatar
South Korea's Samsung Engineering Co. said on Jan. 9 it has signed a 1.6 trillion won ($1.3 billion) contract to build the world's largest ethylene ...
Jan 09, 2023 (Gmt+09:00)
-
Korean food
CJ CheilJedang to expand K-food production facilities overseas
South Korean food giant CJ CheilJedang Corp. is slated to increase food manufacturing facilities globally and launch businesses in Australia, Canada...
Jan 09, 2023 (Gmt+09:00)
-
Regulations
Korea may fine Aramco-backed Hyundai Oilbank $119 mn over wastewater
South Korea is set to impose a fine of 150.9 billion won ($118.9 million) on Hyundai Oilbank Co., a local refiner backed by Saudi Aramco, for allege...
Jan 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Kolon signs MOU with Hanyang Univ. to develop gene therapy treatments
Kolon Industries Inc.'s Future Technology Institute said on Thursday that it had signed a memorandum of understanding with the Hanyang University In...
Jan 05, 2023 (Gmt+09:00)
-
Bio & Pharma
NeoImmuneTech, US think tank to develop treatment for acute radiation syndrome
Biopharmaceutical company NeoImmuneTech has grabbed an opportunity to supply new drug candidates in development as strategic items to the US gover...
Jan 04, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion's Remsima receives approval in 100 countries in 10 years
South Korea's most valuable biopharmaceutical company Celltrion Inc. said on Tuesday that its antibody biosimilar Remsima (ingredient: infliximab) h...
Jan 03, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB confirms ophthalmic disease treatment in phase 3 clinical trials
South Korea’s biomedicine startup HLB Therapeutics Co. said on Monday that its Neurotrophic Keratopathy (NK) treatment RGN-259 proved effectiv...
Jan 03, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Chemicals introduces Tiglutik, treatment for Lou Gehrig's disease
SK Chemicals said on Monday that it is strengthening its portfolio of neurological diseases by introducing Tiglutik (riluzole), Lou Gehrig's disease...
Jan 02, 2023 (Gmt+09:00)
-
Electric vehicles
Hyundai to consider EV assembly plant in Saudi Arabia
Hyundai Motor Group, South Korea’s top automaker, plans to consider building an assembly plant for electric vehicles and internal combustion e...
Jan 01, 2023 (Gmt+09:00)
-
Bio & Pharma
CJ applies to FDA for trials of immuno-anticancer drug candidate
CJ Bioscience, an independent red bio (pharmaceutical and healthcare) subsidiary of CJ CheilJedang Corp., said on Monday it has submitted a phase 1 ...
Dec 26, 2022 (Gmt+09:00)
-
Bio & Pharma
CENYX Biotech, developing treatment for brain damage with ROS-scavenging, nano-sized heavy metals
When severe brain diseases such as cerebral infarction or cerebral hemorrhage occur, the blood-brain barrier (BBB) in our body no longer functions p...
Dec 26, 2022 (Gmt+09:00)
-
Bio & Pharma
LegoChem Bio, Amgen sign ADC platform deal for up to $1.2 bn
South Korean pharmaceutical firm LegoChem Biosciences Inc. said on Dec. 23 it has transferred the antibody-drug conjugates (ADC) technology platform...
Dec 23, 2022 (Gmt+09:00)
-
Shipping & Shipbuilding
Samsung Heavy Industries lands $1.5 bn deal for offshore plant order
South Korean shipbuilder Samsung Heavy Industries has bagged a $1.5 billion order to build an offshore plant from an Asian shipper, the company reve...
Dec 23, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for FDA approval for Remsima SC
Celltrion Ltd. said on Friday it had applied the previous day for permission from the US Food and Drug Administration (FDA) for Remsima SC, an autoi...
Dec 23, 2022 (Gmt+09:00)
-
Bio & Pharma
ToolGen, ANLBIO to jointly develop progeria treatments
South Korea's two biotech startups ToolGen Incorporated and ANLBIO on Tuesday signed a joint research and development agreement for developing proge...
Dec 21, 2022 (Gmt+09:00)
-
Bio & Pharma
JW Pharma applies for phase 3 trial in Taiwan for gout treatment
JW Pharmaceutical announced through its disclosure on Monday that it had applied last Friday for a phase 3 trial for Epaminurad, a gout treatment, w...
Dec 19, 2022 (Gmt+09:00)
-
Bio & Pharma
LG Chem in $95.5 million drug out-licensing deal with China’s Innovent
LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., and China’s biotech company Innovent Biologics have entered into a strategi...
Dec 15, 2022 (Gmt+09:00)
-
Bio & Pharma
S. Korea's GI Cell, Japanese partner to study cell therapy for blood cancer
South Korea's GI Cell, the cell therapy affiliate of GI Innovation, on Tuesday said it signed an agreement with Optieum Biotechnologies of Japan on ...
Dec 14, 2022 (Gmt+09:00)
-
Bio & Pharma
LG Chem confirms diabetes drug Zemidapa's efficacy in phase 3 trials
LG Chem Ltd. announced in a disclosure on Monday that it had confirmed superior efficacy in phase 3 clinical trials for the combined administration ...
Dec 13, 2022 (Gmt+09:00)
-
Carbon neutrality
POSCO, Malaysia’s Petros to join forces on carbon capture business
POSCO Holdings Inc., the holding company of South Korea’s top steelmaker POSCO, said on Monday it has joined forces with Malaysia’s ener...
Dec 12, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Biopharmaceuticals launches epilepsy drug in France
South Korean SK Biopharmaceuticals Co. said on Friday that its treatment of epilepsy "Cenobamate" has been approved for sale in France.The company l...
Dec 09, 2022 (Gmt+09:00)
-
Batteries
LG Energy, GM to inject another $275 mn in Tennessee plant
South Korean battery maker LG Energy Solution Ltd. and General Motors Co. plan to inject an additional $275 million in a US electric vehicle battery...
Dec 04, 2022 (Gmt+09:00)
-
Bio & Pharma
Medipost, OmniaBio to enhance cooperation for CDMO business
South Korea's stem-cell therapy company Medipost announced on Thursday that its Canadian affiliate OmniaBio made a two-day visit to South Korea on N...
Dec 01, 2022 (Gmt+09:00)
-
Construction
Hyundai, Daewoo sign Turkmenistan fertilizer plant deals
South Korea’s Hyundai Engineering Co. and Daewoo Engineering & Construction Co. are likely to win orders to build fertilizer plants in Tur...
Nov 30, 2022 (Gmt+09:00)
-
Korean SMEs
LG U+ and Korea Fanuc to devise smart factory solutions for SMEs
Korean telecom giant LG Uplus Corp. on Tuesday said it will develop a smart factory solution for small and medium enterprises (SMEs) jointly with th...
Nov 30, 2022 (Gmt+09:00)
-
Bio & Pharma
Orion to enter dental disease treatment sector
Orion Corp., the Korean company, best known for its signature product choco pie, is entering drug development. Instead of indirectly running a joint...
Nov 30, 2022 (Gmt+09:00)
-
Chemical Industry
SK picglobal builds DPG-only production facility
SK picglobal, a joint venture between SKC's chemical division and a subsidiary of the Kuwait Petroleum Corporation (KPC) named PIC, have built a pla...
Nov 28, 2022 (Gmt+09:00)
-
Construction
Vietnam to get its first Korean-style industrial complex
A groundbreaking ceremony was held Friday for Vietnam's first Korean-style industrial complex, to be built in the country's northern Hung Yen Provin...
Nov 25, 2022 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand